Loading...
Oral encapsulated transforming growth factor β1 reduces endogenous levels: Effect on inflammatory bowel disease
BACKGROUND: TreXTAM(® )is a combination of the key regulatory cytokine transforming growth factor beta (TGFβ) and all trans retinoic acid (ATRA) microencapsulated for oral delivery to immune structures of the gut. It is in development as a novel treatment for inflammatory bowel disease (IBD). AIM: T...
Na minha lista:
| Udgivet i: | World J Gastrointest Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667406/ https://ncbi.nlm.nih.gov/pubmed/33251033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v11.i5.79 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|